menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

The Role of GPRC5D in the Multiple Myeloma Treatment Paradigm

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Related
Comments
  • Overview

    GPRC5D has become a key potential target for many newer multiple myeloma therapies. So how could this address gaps in the current treatment landscape? Dive in with Dr. Charles Turck as he discusses this with Dr. Joshua Richter, Associate Professor of Medicine at the Tisch Cancer Institute in the Division of Hematology and Oncology and the Director of Multiple Myeloma at the Blavatnik Family Chelsea Medical Center at Mount Sinai in New York.

Facebook Comments

Recommended
Details
Presenters
Related
Comments
  • Overview

    GPRC5D has become a key potential target for many newer multiple myeloma therapies. So how could this address gaps in the current treatment landscape? Dive in with Dr. Charles Turck as he discusses this with Dr. Joshua Richter, Associate Professor of Medicine at the Tisch Cancer Institute in the Division of Hematology and Oncology and the Director of Multiple Myeloma at the Blavatnik Family Chelsea Medical Center at Mount Sinai in New York.

Facebook Comments

Schedule28 Feb 2024